GE HealthCare receives FDA 510(k) clearance for Critical Care Suite 3.0 feeding‑tube AI

GE HealthCare announced that the U.S. Food and Drug Administration granted 510(k) clearance for its Critical Care Suite 3.0, an on‑device AI application that detects feeding tubes on mobile X‑ray images for both adult and pediatric patients. The algorithm runs directly on the X‑ray unit without cloud connectivity. Clinical testing showed a 99.2% sensitivity for tube detection and a 91.6% mean DICE score for localization.

The clearance prompted GEHC shares to rise about 2% after the announcement, reflecting investor optimism that the new capability will boost demand for the company’s mobile imaging systems (source 5).

  • 1The FDA granted 510(k) clearance for Critical Care Suite 3.0, enabling on‑device feeding‑tube detection for adult and pediatric patients.
  • 2The AI runs directly on compatible mobile X‑ray devices and does not require internet or cloud connectivity.
  • 3Clinical testing demonstrated 99.2% sensitivity for tube detection.
  • 4The algorithm achieved a 91.6% mean DICE localization score compared with expert radiologist annotations.
  • 5GEHC stock gained more than 2% following the announcement.
  • 6GE HealthCare’s market capitalization is $37.51 billion.

Sources